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In response to many apoptotic stimuli, oligomeriza-
tion of Bax is essential for mitochondrial outer
membrane permeabilization and the ensuing release
of cytochrome c. These events are accompanied by
mitochondrial fission that appears to require Drp1,
a large GTPase of the dynamin superfamily. Loss of
Drp1 leads to decreased cytochrome c release by
a mechanism that is poorly understood. Here we
show that Drp1 stimulates tBid-induced Bax oligo-
merization and cytochrome c release by promoting
tethering and hemifusion of membranes in vitro. This
function of Drp1 is independent of its GTPase activity
and relies on arginine 247 and the presence of cardio-
lipin in membranes. In cells, overexpression of Drp1
R247A/E delays Bax oligomerization and cell death.
Our findings uncover a function of Drp1 and provide
insight into the mechanism of Bax oligomerization.
INTRODUCTION
In mammalian cells undergoing apoptosis, many proteins that
are confined to the intermembrane space of mitochondria are
released as a result of the mitochondrial outer membrane (MOM)
becomingpermeable.Permeabilizationof theMOMisensuredby
proapoptotic members of the Bcl-2 family such as Bax or Bak
(Kroemer et al., 2007; Schinzel et al., 2004). Whereas Bak is an
integral MOM protein, Bax is inactive in the cytosol and soluble,
or loosely attached to mitochondria, until it is activated by
a diverse array of apoptotic stimuli (Youle and Strasser, 2008).
Bax then undergoes conformational changes, translocates, and
inserts into the MOM and oligomerizes, inducing MOM permea-bilization (MOMP). These conformational rearrangements occur
in the MOM and require a tight cooperation between Bax or
Bak, BH3-only proteins, and the lipid bilayer (Lucken-Ardjo-
mande and Martinou, 2005). The current model postulates that
tBid serves as a receptor for Bax, allowing its insertion and oligo-
merization in the membrane (Lovell et al., 2008). Other BH3-only
proteins such as Bim, MAP-1, or Puma could also directly bind
and recruit Bax in the MOM as does tBid (Certo et al., 2006;
Gallenne et al., 2009; Gavathiotis et al., 2008; Marani et al.,
2002; Tan et al., 2005; Walensky et al., 2006). Moreover, compo-
nents of the TOM complex and Endophilin B1/Bif-1 appear to be
important to fine-tune Bax insertion and oligomerization (Bellot
et al., 2006; Etxebarria et al., 2008; Ott et al., 2007). Several find-
ings also suggest that components of the mitochondrial fission
machinery, including the large GTPase of the dynamin super-
family Drp1 (Heymann and Hinshaw, 2009), may play a role in
MOMP and cytochrome c release (Youle and Strasser, 2008).
We previously reported that although tBid appears to be
sufficient to trigger Bax oligomerization in synthetic liposomes
(Kuwana et al., 2002; Lovell et al., 2008; Lucken-Ardjomande
et al., 2008; Terrones et al., 2004), additional proteins are
required to induce efficient Bax oligomerization in the MOM
(Roucou et al., 2002). We searched for these proteins using
a minimal cell-free assay and identified Drp1 as a protein
capable of stimulating oligomerization of Bax upon its insertion
into liposomes.We provide strong evidence that Drp1 stimulates
Bax oligomerization by promoting membrane remodeling.RESULTS
Drp1 Stimulates tBid-Dependent Bax Oligomerization
in Liposomes
Our previous work showed that a MOM-associated protein is
required to induce efficient tBid-induced Bax oligomerizationCell 142, 889–901, September 17, 2010 ª2010 Elsevier Inc. 889
Figure 1. Drp1 Promotes Bax Oligomerization in the Presence of tBid
(A) PC/PE/CL (54/20/26mol%) liposomeswere incubatedwith the indicated proteins at 30C for 30min before ultracentrifugation, resuspension in KCl buffer, and
incubation with trypsin for 2 hr at 30C. Trypsin-resistant Bax (Tr-Bax) was analyzed by immunoblotting. M: salt-extracted liver mitochondrial proteins (400 mg);
LC: rat liver cytosolic extract (200 mg); BC: rat brain cytosolic extract (200 mg); BC-PK: BC (200 mg) treated with proteinase K. Bax (50 nM); tBid (10 nM); tBidDBH3
(10 nM); Bcl-xL (1 mM). The blot is representative of three independent experiments.
(B) Purification steps of Bax-activating proteins: silver-stained SDS-polyacrylamide gel electrophoresis of BC proteins fractionated by size-exclusion chroma-
tography (top panel); Bax-activating proteins (assessed as in A) are found in P1–P3 fractions (lower panel). Blots are representative of at least three independent
experiments. P1 displayed the highest specific BAF activity and was found to contain GAPDH, Aldolase, Tubulin, Microtubule-Associated Protein 1, Dynein,
Spectrin, Actin, Gelsolin, Alpha Actinin, Cofilin, and Drp1. Except Drp1, all proteins were found to be inactive in the Bax oligomerization assay.
(C) Immunoblot showing that Drp1 is present in P1–P3 fractions.
(D) Dose-response analysis of in vitro tBid-induced Bax oligomerization with increasing concentrations of recombinant Drp1. PC/PE/CL liposomes were incu-
bated with 10 nM tBid and 50 nM Bax and increasing amounts of recombinant Drp1 before trypsin digestion and Bax analysis. Upper immunoblots show levels
of Drp1 and Bax before trypsin digestion. The blot is representative of three independent experiments.
(E) Analysis of tBid-induced Bax oligomerization in isolated liposomes in the absence or presence of 1 mM Drp1 by size-exclusion chromatography. PC/PE/CL
liposomes were incubated with 10 nM tBid, 50 nM Bax, and 1 mM Drp1. Liposomes were then lysed in 2% CHAPS, 200 mM NaCl and proteins fractionated by
size-exclusion chromatography. The elution profile of Bax was analyzed by immunoblotting.
(F) Upper panel: western blot analysis of Drp1 in control (shLuc) and Drp1-depleted (shDrp1) HeLa cells. Lower panel: analysis of Bax-activating capacity of
control and Drp1-depleted HeLa cytosolic extracts (200 mg each). Brain cytosol (BC) was also tested at 200 mg. In each experiment, the same cytosolic extract
from HeLa cells was tested in duplicate. The experiment was repeated twice, using the same cell lines but with a different cytosolic extract preparation.(Roucou et al., 2002). To identify this protein, we took advantage
of a recently described acellular assay to monitor Bax oligomer-
ization, based on the observation that Bax oligomers are
partially resistant to trypsin (Goping et al., 1998; Lucken-Ardjo-
mande et al., 2008). In line with our previous data, when incu-890 Cell 142, 889–901, September 17, 2010 ª2010 Elsevier Inc.bated with tBid and liposomes containing phosphatidylcholine,
phosphatidylethanolamine, and cardiolipin (PC/PE/CL lipo-
somes), a fraction of Bax became resistant to trypsin proteolysis
(Figure 1A). Addition of high salt-extracted liver mitochondrial
proteins stimulated tBid-induced Bax oligomerization,
confirming the presence of a Bax-activating factor (BAF) in this
extract (Figure 1A). In addition, we found that cytosolic extracts
from rat liver or brain, or HeLa cells, also stimulated Bax
oligomerization (Figures 1A and 1F). Bax activation required
the presence of a functional tBid BH3 domain and was pre-
vented by Bcl-xL (Figure 1A). Proteolysis of the brain cytosolic
extract with proteinase K abolished BAF activity. Thus, BAF(s)
is/are protein(s) present in the cytosol or weakly attached to
mitochondria.
Because of its high BAF-specific activity, the brain cytosolic
extract was selected for biochemical purification of BAF. Cation
exchange and size exclusion chromatographies allowed enrich-
ment of BAF-specific activity in high-molecular-weight fractions
(P1–P3; Figure 1B). However, purification to homogeneity was
not achieved due to a loss of activity during additional purifica-
tion steps. We therefore decided to identify by mass spectrom-
etry and/or western blot analysis the proteins present in P1,
which displayed the highest specific activity, and to test them
individually in the Bax activation assay. Negative results were
obtained with a number of different proteins (data not shown,
see the list in the legend of Figure 1B), until we identified and
tested Drp1 (Figure 1C). Recombinant Drp1 was able to activate
Bax in a dose-dependent manner (Figures 1D and 1E), only in the
presence of tBid (data not shown). To test whether Drp1 was
responsible for the BAF activity present in the cytosolic extracts,
we compared the activity of cytosolic extracts from control HeLa
cells (expressing shLuc) and fromHeLa cells depleted of Drp1 by
RNA interference (shDrp1) (Parone et al., 2006). Drp1 depletion
decreased the activity of the cytosol (Figure 1F), implicating it
in Bax oligomerization. However, a residual activity was still
present in the Drp1-depleted cytosol perhaps because of an
incomplete removal of Drp1 or because of the existence of addi-
tional BAFs.
Cardiolipin Binding Is Essential for Drp1’s Ability
to Promote Bax Oligomerization
tBid has been previously reported to preferentially bind mito-
chondrial contact sites, to display a strong affinity for the nega-
tively charged phospholipid CL (Lutter et al., 2000 and
Figure 2B), and to promote Bax oligomerization in CL-containing
membranes (Kuwana et al., 2002; Lucken-Ardjomande et al.,
2008). The concentration of CL at contact sites has been
reported to represent around 25% of the phospholipid content
(Ardail et al., 1990). This corresponds to the CL composition of
the liposomes used in our study. When the amount of CL was
reduced to 10%, a significant effect of Drp1 on tBid-induced
Bax oligomerization was also observed, although less important
than the effect obtained with liposomes containing higher CL
concentrations (Figure 2A). In addition we found that Drp1 had
a stronger affinity for CL than for phosphatidylserine (PS),
another negatively charged phospholipid (Figure 2B), whereas
the integral membrane protein hFis1, used as a control, bound
equally well to CL- or PS-containing liposomes (Figure 2B). As
both tBid and Drp1 showed an affinity for CL, the question arose
as to whether tBid could alter binding of Drp1 to liposomes or
vice versa. Figure S1 (available online) shows that, under our
experimental conditions, the binding of tBid and Drp1 was not
significantly different whether the proteins were added alone ortogether, in the presence of Bax. Binding of Drp1 to CL could
be mediated by electrostatic interactions between negative
charges of the phospholipid and positively charged amino acids
exposed at the surface of the protein. We therefore mutated
a number of these amino acids, including R201, R247, K255,
and K256 of the GTPase domain of Drp1 (Figure S2A). Mutation
of these residues, except R247, did not alter binding to lipo-
somes (data not shown). Arginine 247 is a residue that is
exposed at the surface of Drp1 and is conserved between
dynamins 1 and 2 and Drp1 of various species (Figures S2A
and S2B). Mutations of R247 to an alanine or a glutamic acid
(Drp1 R247A/E) significantly impaired the ability of Drp1 to bind
CL-containing liposomes (Figure 2C), without impairing the
GTPase activity of the protein (Figure 2D). In addition, the mutant
proteins proved to be less efficient in promoting Bax oligomeri-
zation (Figure 2E), indicating that the binding of Drp1 to CL-
containing liposomes is required for stimulating tBid-induced
Bax oligomerization.
Drp1 Stimulates Bax Oligomerization Independently
of Its GTPase Activity
Because Drp1 is a large GTPase of the dynamin family, we
further tested whether its GTPase activity was necessary to
promote tBid-induced Bax oligomerization. Key amino acids
in the GTPase domain were mutated to produce GTPase-defi-
cient mutants (Drp1 K38A, Drp1D1-38, and Drp1 T59A/G149A/
K216A) (Figure 2D). Interestingly, all of these mutants were still
capable of stimulating Bax oligomerization (Figure 2F), indicating
that the GTPase activity of Drp1 is dispensable for Bax oligomer-
ization. Supporting this finding, the buffer used to assay BAF
in vitro did not contain GTP. However, it contained ATP, the
role of which was therefore tested. In the presence of cytosol
or Drp1 and tBid, but without ATP, Bax oligomerization dropped
to the level obtained in the presence of Bax and tBid alone
(Figure 2G, left blot), indicating that ATP was important for
Drp1 to stimulate tBid-induced Bax oligomerization. Other
nucleotides, including GTP, GTPgS, ADP, and AMP, could
not substitute for ATP (Figure 2G, right blot), unless used at
supraphysiological concentrations (>5 mM; data not shown).
In contrast, the nonhydrolyzable ATP analog AMPpNp was
almost as efficient as ATP, indicating that hydrolysis of ATP
was not required for Bax activation (Figure 2G). Accordingly,
we excluded the possibility that Drp1 acted as an ATPase
(data not shown).
ATP was not required for membrane binding of Drp1
(Figure 2C) but proved to have an impact on its quaternary struc-
ture in the presence of liposomes. In agreement with previous
data, Drp1 was purified as a tetramer as assessed by size exclu-
sion chromatography (Zhu et al., 2004). In the presence of either
ATP alone (data not shown) or Bax, tBid, and CL-containing lipo-
somes (Figure 2H), Drp1 remained tetrameric. However, in the
presence of ATP, tBid, Bax, and liposomes, it was eluted in large
molecular weight (MW) fractions, suggesting that the protein
formed larger oligomers. A similar elution profile was obtained
in the absence of tBid and Bax (data not shown). Drp1 present
in the large MW fractions migrated as both a monomer
(80 kDa) and a dimer (160 kDa) on SDS-PAGE, suggesting
incomplete disassembly by the SDS present in the bufferCell 142, 889–901, September 17, 2010 ª2010 Elsevier Inc. 891
Figure 2. Drp1 Acts Independently of Its GTPase Activity and Requires ATP, and Its Binding to Cardiolipin Is Essential for tBid-Induced Bax
Oligomerization
(A) PC/PE/CL liposomes were prepared with increasing concentrations of CL and concomitant reduction of PC. They were incubated with 10 nM tBid
and 50 nM Bax and with 200 mg brain cytosol or 500 nM Drp1 before trypsin digestion and Bax analysis. This blot is representative of three independent
experiments.
(B) Preferential binding of Drp1 and tBid to CL. Liposomes with increasing amounts of CL (PC/PE/CL, left panel) or PS (PC/PE/PS, right panel) were incubated in
the presence of Drp1 (1 mM) or tBid (10 nM), centrifuged, and analyzed by western blotting for the presence of Drp1 or tBid in the pellet or the supernatant. As
a control, liposomes were incubated with the integral membrane protein hFis1. Each panel represents a separate experiment. This blot is representative of two
independent experiments. See also Figure S1.
(C) PC/PE/CL (54/20/26) liposomes were incubated with Drp1 R247A or Drp1WT (500 nM each) alone in the presence or absence of ATP and loaded on a sucrose
gradient before ultracentrifugation. Drp1 R247A and Drp1WTwere analyzed by immunoblotting in the suspension before gradient centrifugation and after centri-
fugation in the floating liposomal suspension. This blot is representative of three independent experiments.
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Figure 3. Drp1 Triggers Membrane Tethering
(A) Fluorescence microscopy images of PC/PE/CL liposomes containing 1% NBD-PE in the presence of ATP and the presence or absence of 1 mM Drp1.
(B) Dose-response of liposome aggregation in the presence of increasing concentrations of Drp1 (black line). Proteinase K was added to aggregated liposomes
and the turbidity of the liposome suspension was measured 5 min later (gray line). Turbidity of the suspension was measured at 450 nm. DOD (optical density)
values represent the difference between OD450 of the liposome suspension incubated in the presence of proteins and OD450 values in the absence of proteins.
Results are means of three independent experiments ± SD.(Figure 2H). This dimer was also detected by SDS-PAGE and
Coomassie staining upon incubation of 500 nM Drp1 with lipo-
somes and ATP (Figure 2I and see also Figure 2C). Further
studies are necessary to determine how ATP promotes forma-
tion of high-order Drp1 oligomers.
Drp1 Promotes Tethering and Hemifusion
of Cardiolipin-Containing Membranes
Interestingly, in the presence of ATP, liposomes clustered in
a Drp1 dose-dependent manner, as shown by visual observation
(Figure 3A) and by a characteristic rise in the turbidity of the
liposome suspension (Nakatogawa et al., 2007) (Figure 3B).
These aggregates disappeared after the addition of proteinase
K, indicating that Drp1 was responsible for membrane tethering
(Figure 3B).
Liposome aggregation could simply represent membrane
bridging but could also represent hemifusion (i.e., fusion of the
outer leaflets of adjacent membranes, while inner leaflets remain
intact) or complete fusion (i.e., the merger of both inner and outer
leaflets) of apposed membranes. In order to test these possibil-
ities, we used a lipid-mixing assay, which is based on fluores-
cence resonanceenergy transfer from1,2-dioleoyl-sn-glycero-3-(D) GTPase activity of Drp1 WT and Drp1 mutants (1 mM each). Values are mean
mutants differed from WT with ***: p < 0.001.
(E) Comparison of the effects of Drp1 WT, Drp1 R247A, and Drp1 R247E (1 mM ea
in the presence of 10 nM tBid, 50 nM Bax, and the indicated proteins before tryp
experiments. See also Figure S2.
(F) Analysis of Drp1 GTPasemutants (1 mMeach) for their capacity to stimulate tBid
three independent experiments.
(G) In vitro analysis of tBid-induced Bax oligomerization in the absence or presenc
2.5 mM (right blot). Experiments were performed in the presence or absence of 1
spond to the same membrane and identical exposure times). Upper blots show B
experiments.
(H) Analysis of Drp1 by size-exclusion chromatography. Liposomes were incubate
2.5 mM ATP, solubilized with CHAPS, and separated by size-exclusion chromat
(I) Drp1 (1 mM)was incubatedwith liposomes and/or 2.5mMATP, run on a polyacry
after transfer to a nitrocellulose membrane. The arrow points to Drp1 dimers.phosphatidylethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4yl)
(NBD-PE) to 1,2-dioleoyl-snglycero-3-phosphoethanolamine-N-
(lissamine rhodamine B sulfonyl) (Rho-PE) (Struck et al., 1981).
PC/PE/CL large unilamellar vesicles (LUVs) were prepared with
or without addition of NBD-PE and Rho-PE. When the two dyes
are present at an appropriate concentration in the same lipo-
some, the fluorescence of NBD is quenched by rhodamine.
Upon fusion of these LUVs with unlabeled LUVs, the distance
between the two dyes increases, resulting in a dequenching of
NBD fluorescence. When the two LUV populations were mixed
in the presence of Drp1, NBD fluorescence increased in a time-
and dose-dependent manner, indicating that lipid mixing had
occurred (Figures 4A–4C). The level of NBD fluorescence
induced by Drp1 was about 50% of that obtained upon addition
of detergent, which provides the maximum level of fluorescence
(100%). As expected, the extent of lipid mixing obtained with
Drp1 R247A was significantly reduced compared to Drp1 wild-
type (WT) (Figures 4B and 4C). On the other hand, no increase
in NBD fluorescence was measured with heat-denatured Drp1
or when Drp1 was incubated in the presence of labeled LUVs
alone (Figure 4B). Finally, consistent with the preferential binding
of Drp1 to CL, replacing this phospholipid with PS, maintainings of three independent experiments ± standard deviation (SD). Drp1 GTPase
ch) on tBid-induced Bax oligomerization. PC/PE/CL liposomes were incubated
sin digestion and Bax analysis. The blot is representative of three independent
-induced Bax oligomerization. Blots show duplicates and are representative of
e of ATP (left blot) or in the presence of ATP or other nucleotides, each tested at
mMDrp1 or 200 mg brain cytosol (BC) (right blot; the two parts of this blot corre-
ax binding to liposomes. Blots are representative of at least three independent
d with Drp1 (1 mM), Bax (50 nM), and tBid (10 nM) in the presence or absence of
ography, and the elution profile of Drp1 was analyzed by immunoblotting.
lamide gel under nonreducing conditions, and detected byCoomassie staining
Cell 142, 889–901, September 17, 2010 ª2010 Elsevier Inc. 893
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the net charge of the vesicles, completely abolished the ability of
Drp1 to trigger an increase in NBD fluorescence (Figure 4D).
Thus,CL is critical forDrp1-induced lipidmixing. A similar conclu-
sion was reached when lipid mixing was monitored by fluores-
cence-activated cell sorting (FACS) analysis (Figures S3A and
S3B). We then investigated whether Drp1-induced lipid mixing
resulted from complete membrane fusion or membrane hemifu-
sion. We prepared asymmetrically labeled liposomes by adding
the membrane-impermeable reductant sodium dithionite to the
liposome suspension to selectively quench the fluorescence of
NBD in the outer leaflet. The validity of the assay was checked
with calcium, which is known to trigger complete fusion (Ortiz
et al., 1999). In the presence of 10 mM CaCl2, a significant
increase in NBD fluorescence was still measured upon incuba-
tion of dithionite-treated LUVs with unlabeled LUVs, indicating
that fusion of the inner leaflets of apposed membranes, i.e.,
complete fusion of vesicles, had occurred (Figure 4B). In contrast
to calcium, under these conditions, Drp1 WT or Drp1 R247A had
a small impact on NBD fluorescence, indicating that Drp1 mainly
triggers fusion of the outer leaflet withminimal inner leafletmixing
(Figures 4A and 4B). Consistent with these results, no fusion pore
formation and content mixing occurred in the presence of
Drp1. This result was established using the content-mixing fusion
assay where liposomes filled with 8-aminonaphthalene-1,3,6-
trisulfonic acid (ANTS) are mixed with liposomes filled with p-xy-
lylenebis(pyridinium bromide) (DPX) (Ellens et al., 1985). Vesicle
fusion results in quenching of ANTS fluorescence. As a positive
control, we used phospholipase C (PLC) from Bacillus cereus
that had previously been reported to induce membrane fusion
(Basanez et al., 1996) (Figure 4E). In contrast to PLC, neither
Drp1WT nor Drp1 R247A induced aqueous content mixing, indi-
cating that Drp1 does not trigger lipid pore formation and
complete membrane fusion (Figure 4E).Figure 4. Drp1 Potentiates tBid-Induced Bax Oligomerization by Prom
(A) Representative time courses of total lipid mixing (Tot. Mix.) and inner monolay
mixing was monitored by the NBD/Rhodamine lipid dilution assay. For inner m
amounts of sodium dithionite to quench NBD fluorescence of the outer leaflet.
5 min before protein addition. The extent of lipid mixing was quantified on a per
the measured fluorescence of protein-treated LUVs at time t, F0 is the initial fluore
cence value after complete disruption of LUVs by addition of 10mM b-octylglucos
sion and the second arrow denotes addition of OG.
(B) Comparison of the degree of total lipid mixing and inner monolayer lipid mixing
WT) and 10 mMCaCl2. As a control, Drp1 WT was incubated with NBD/Rho conta
of total lipidmixing value corresponds to LUVs treated with OG.Mean values ± sta
iments. Drp1 WT differed from Drp1 R247A with ***p < 0.001. See also Figure S3
(C) Dose-response of Drp1 WT and Drp1 R247A on total lipid mixing.
(D) Lipid mixing elicited by Drp1 WT in LUVs containing either PC (100), PC/PE/C
independent experiments. PC and PC/PE/PS differed from PC/PE/CL with ***p <
(E) Comparison of the degree of aqueous content mixing elicited by Drp1 WT, Dr
lipase C from Bacillus cereus (PLC). Content mixing was monitored by ANTS/DPX
LUVs containing both 12.5mMANTS and 45mMDPX. Drp1WTwas incubated wi
three independent experiments. Drp1 WT, Drp1 R247A, and heated Drp1 WT dif
(F) Total lipid mixing induced by 158 nM Drp1WT in PC/PE/CL vesicles upon exte
SEM are shown for three to seven independent experiments. Each LPC, LPE, an
significantly different (ns).
(G) PC/PE/CL liposomes containing 9 or 18 mol% LPC were used in in vitro Bax
representative of three independent experiments.
(H) PC/PE/CL liposomes were incubated with tBid and Bax and increasing concen
is representative of three independent experiments.According to the widely accepted stalk-pore fusion model
(Chernomordik and Kozlov, 2008), hemifusion is thought to start
with the formation of a stalk, a local connection between the con-
tacting monolayers of two membranes. The stalk then extends
connecting the facing monolayers (hemifusion) before pore
formation (fusion) occurs. The model predicts that addition of
inverted cone-shaped lipids (i.e., positive curvature-inducing
lipids) such as lyso-phosphatidylcholine (LPC) or lyso-phospha-
tidylethanolamine (LPE) to contacting membrane leaflets should
prevent formation of hemifused intermediates (Chernomordik
et al., 1995), whereas cone-shaped lipids such as oleic acid
(OA), which induce negative curvatures, should promote forma-
tion of hemifusion intermediates. Therefore, to confirm that Drp1
induced lipid mixing through formation of hemifusion intermedi-
ates, we added sublytic concentrations of LPC or LPE (Cherno-
mordik et al., 1993) or OA to the vesicles (Figure 4F; see also
Figure S3C). Addition of LPC or, to a lesser degree, LPE that
possesses a less positive intrinsic curvature than LPC signifi-
cantly decreased total lipid mixing induced by Drp1 in a dose-
dependent manner. On the other hand, addition of OA slightly
promoted Drp1-induced lipid mixing. When OA and LPC were
added together, OA was able to counteract the inhibitory effect
of LPC on lipid mixing. These data strongly argue that Drp1-
induced lipid mixing is mediated by formation of membrane
hemifusion intermediates.
Membrane Hemifusion Is Sufficient to Stimulate
tBid-Induced Bax Oligomerization
Whereas LPC significantly reduced membrane hemifusion
induced by Drp1, it also blocked the effect of Drp1 on Bax olig-
omerization (Figure 4G), suggesting that the capacity of Drp1
to facilitate tBid-induced Bax oligomerization is related to its
capacity to promote membrane hemifusion.oting Hemifusion of Cardiolipin-Containing Membranes
er lipid mixing (Inn. Mix.) induced by 225 nM Drp1 WT in PC/PE/CL LUVs. Lipid
onolayer lipid mixing, NBD + Rho-liposomes were treated with appropriate
Unlabeled and NBD + Rho-labeled liposomes were mixed and incubated for
centage basis according to the equation: (FtF0)/(F100F0) 3 100 where Ft is
scence of the LUV suspension before protein addition, and F100 is the fluores-
ide (OG). First arrow shows time of addition of Drp1WT to the liposome suspen-
elicited by Drp1 WT, Drp1 R247A, and heat-denatured Drp1 WT (Heated Drp1
ining LUVs but in the absence of unlabeled LUVs (Cont.). One hundred percent
ndard error of themean (SEM) are shown for three to seven independent exper-
.
L (54/20/26), or PC/PE/PS (28/20/52). Mean values ± SEM are shown for three
0.001.
p1 R247A, heat-denatured Drp1 WT (Heated Drp1 WT), and 0.1 nM Phospho-
aqueous content mixing assay; 100% of content mixing was determined using
th ANTS containing LUVs as a control (Cont.). Mean values ±SEMare shown for
fered from PLC with ***p < 0.001.
rnal addition of indicated concentrations of LPC, LPE, and OA. Mean values ±
d OA concentration differed from 0% with **p < 0.01, ***p < 0.001, or was not
oligomerization assays. Drp1 was used at 1 mM. Blot shows duplicates and is
trations of cytochrome c at pH 6 before assaying Bax oligomerization. The blot
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Cytochrome c at pH 6 has previously been reported to
stimulate membrane hemifusion (Kawai et al., 2005). To
demonstrate further the role of membrane hemifusion as the
mechanism mediating the effect of Drp1 on tBid-induced
Bax oligomerization, we tested whether hemifusion triggered
by cytochrome c at pH 6 (Figure S3D) would also promote
Bax oligomerization. We found that tBid-induced Bax oligo-
merization was enhanced by increasing concentrations of
cytochrome c at pH 6 (Figure 4H), indicating that rather than
Drp1 per se, it is the membrane hemifusion process that is
directly responsible for potentiating tBid-induced Bax oligo-
merization.
Overexpression of Drp1 R247A or Drp1 R247E Delays
Apoptosis
We tested the physiological relevance of part of our findings
in cellulo. We first analyzed the migration pattern of Drp1
from HeLa cells undergoing actinomycin D (ActD)-induced
apoptosis by SDS-PAGE. In agreement with previous data
(Breckenridge et al., 2003; Frank et al., 2001; Wasiak et al.,
2007), we observed that Drp1 was recruited to mitochondria
during apoptosis (Figure 5A). Moreover, consistent with the
data obtained with liposomes, we found that a proportion of
Drp1 was detected as an 160 kDa band on SDS-PAGE, sug-
gesting that Drp1 oligomerizes during apoptosis. We then
expressed Drp1 R247A/E mutants in HeLa cells and tested their
impact on mitochondrial morphology, Bax oligomerization, and
cytochrome c release during apoptosis (Figures 5B–5D and
Figures 6A–6E). Drp1 R247 A/E was found to coimmunoprecipi-
tate with Drp1 WT, indicating that they likely formed hetero-
oligomers (Figure S4). Importantly, in 80% of cells expressing
mutant Drp1 R247E, mitochondria formed very elongated
tubules, which showed a number of vesicular dilatations (Fig-
ures 5B–5D). These morphological alterations of mitochondria
suggest that, despite a normal GTPase activity, Drp1 R247A/E
has an impaired fission activity and exerts a dominant-negative
effect over endogenous Drp1. Taken together with the weaker
binding of Drp1 R247A to CL-containing liposomes, these
findings suggest that CL could play a role in the mitochondrial
recruitment and/or activity of Drp1, in a manner similar to
what has been previously shown for the assembly of the dyna-
min-related protein Mgm1 in the inner mitochondrial membrane
(DeVay et al., 2009).
Bax oligomerization, monitored by the trypsin digestion assay
(Figures 6B and 6C), by size exclusion chromatography
(Figure 6E), or by crosslinking (Figure S5), and MOMP, analyzed
through the release of cytochrome c (Figure 6D), were signifi-
cantly decreased in both Drp1 R247A/E and Bcl-2 expressing
cells compared to cells transfected with an empty vector or
to cells overexpressing Drp1 WT. Thus, expression of Drp1
R247A/E significantly decreased Bax oligomerization and
MOMP in vivo. As a consequence, cells expressing the Drp1
mutants were more resistant to apoptosis than cells expressing
equivalent amounts of Drp1 WT or than cells transfected with an
empty plasmid when exposed to 3 mM ActD or UV irradiation
(Figures 7A and 7B). Although the protection was significant
at 6 hr after exposure to the stress stimulus, no protection
was observed after 24 hr (data not shown), consistent with896 Cell 142, 889–901, September 17, 2010 ª2010 Elsevier Inc.previously published results (Parone et al., 2006; Sheridan
et al., 2008; Estaquier and Arnoult, 2007). This indicates that
other mechanisms can substitute for Drp1 to trigger Bax
oligomerization.
DISCUSSION
Inhibition of Drp1 has previously been reported to delay
cytochrome c release and apoptosis in vitro (Brooks et al.,
2007; Frank et al., 2001; Germain et al., 2005; Ishihara et al.,
2009; Lee et al., 2004; Cassidy-Stone et al., 2008). Moreover,
Drp1 null mouse embryos fail to undergo developmentally
regulated apoptosis during neural tube formation in vivo
(Wakabayashi et al., 2009). Our results now explain that Drp1
participates in apoptosis by stimulating Bax oligomerization,
thereby enhancing MOMP. By promoting Bax oligomerization
and massive cytochrome c efflux, Drp1 could ensure that mito-
chondrial function is irreversibly altered during apoptosis, and
that a sufficient amount of cytochrome c is released to activate
APAF1. This would prevent cells from recovering after MOMP,
a scenario that has been shown in cells expressing low caspase
activity and high levels of GAPDH (Colell et al., 2007). Drp1 may
therefore correspond to the previously described macromolec-
ular cytosolic factor termed PEF (permeability enhancing factor),
which was defined as a proteinaceous macromolecule able to
enhance MOMP by tBid and Bax (Kluck et al., 1999).
Furthermore, we report that, in vitro, Drp1 promotes Bax olig-
omerization by triggering membrane tethering and hemifusion,
independently of its GTPase activity. We provide evidence
that rather than a direct interaction between Bax and Drp1,
which we have not been able to detect (data not shown), forma-
tion of a Drp1-induced membrane hemifusion intermediate
promotes tBid-induced Bax oligomerization. This membrane
structure promoted by Drp1 in a reconstituted systemmay reca-
pitulate the membrane remodeling that occurs at mitochondrial
fission sites in cells undergoing apoptosis. Indeed, analogous
to membrane fusion, membrane fission also proceeds via a
pathway of intermediate structures. It has been shown that
at membrane constriction sites, dynamins would pinch the
membrane and bring into contact the inner leaflets of the
membrane, allowing the formation of what has been called
a hemifission intermediate (Kozlovsky and Kozlov, 2003). Thus,
during mitochondrial fission, Drp1 could constrict the MOM
and trigger the formation of a hemifission intermediate at fission
sites (see Figure 7C for a model). The occurrence of this mito-
chondrial membrane remodeling during apoptosis may provide
the appropriate membrane curvature, lipid composition, and/or
lateral pressure profile that are considered to be important for
integral membrane protein oligomerization (Basan˜ez et al.,
2002; Lucken-Ardjomande et al., 2008; van den Brink-van der
Laan et al., 2004) and may explain the preferential localization
of Bax at mitochondrial fission sites in apoptotic cells (Karbowski
et al., 2002).
Our data also suggest that any mechanism that would lead
to formation of membrane hemifusion intermediates during
apoptosis may promote Bax oligomerization. Indeed, in the lipo-
some assay, cytochrome c, which is able to trigger membrane
hemifusion at pH 6, triggered tBid-induced Bax oligomerization
Figure 5. Drp1 Oligomerization during Apoptosis and Impact of Drp1 247A/E Mutants on Mitochondrial Morphology
(A) Mitochondrial and cytosolic extracts were prepared from HeLa cells cultured in the absence (time 0) or in the presence of ActD (3 mM) for 2, 4, and 6 hr. Cell
extracts were separated by SDS-PAGE in the absence of DTT and analyzed for Drp1 by western blotting. Hsp90 and mHsp70 were used as loading controls for
cytosolic and mitochondrial extracts, respectively. The blots are representative of four independent experiments.
(B–D) HeLa cells were transfectedwith an empty DNA vector (pCI) or with plasmids encoding Drp1WT or Drp1 R247E together with amitochondria-targeted YFP.
Forty-eight hours later, Drp1 expression levels were quantified in total cell extracts by western blot using an antibody to Drp1. Actin was used as a loading control.
In parallel, mitochondrial morphology was analyzed by fluorescence microscopy. (B) Immunoblot shows that cells transfected with plasmids encoding Drp1 WT
or Drp1 R247E expressed equivalent amounts of Drp1 WT and Drp1 R247E proteins. Actin was used as a loading control. See also Figure S4. (C) Morphology of
mitochondria in HeLa cells observed by fluorescence microscopy. White arrow denotes the presence of vesicular dilatations whereas arrowhead denotes highly
elongated mitochondria. Bar is 5 mm. (D) Quantification of mitochondrial morphology. Mitochondria were divided into three classes: small tubular, which corre-
sponds to cells mainly filled with small filaments of2 mmor less; fragmented that corresponds to punctiformmitochondria; highly elongated, which corresponds
to cells mainly filled with mitochondria >5 mm. Mean values ± SEM are shown for three independent experiments.as well as Drp1. Privileged sites where such a membrane
remodeling could occur are contact sites between the inner
and outer mitochondrial membranes, which are higly enriched
in CL (Ardail et al., 1990). In addition to stimulating Bax oligomer-ization, formation of hemifusion/hemifission intermediates could
modify elasticity of the membrane through changes in lipid
composition or structure and possibly the size of pores formed
by the Bax oligomers. On the other hand, formation of the BaxCell 142, 889–901, September 17, 2010 ª2010 Elsevier Inc. 897
Figure 6. Expression of Drp1 R247A/EMutants Decreases Cytochrome cRelease and Bax Oligomerization in Response to Apoptotic Stimuli
(A) In all experiments performed to assess cytochrome c release, Bax oligomerization, and cell death (Figure 7), HeLa cells were transfected with an empty vector
(pCI) or with plasmids encoding Bcl-2, Drp1 WT, or Drp1 R247A/E. The efficacy of transfection varied between 60% and 80%. Drp1WT and Drp1 R247A/E were
overexpressed at equivalent levels as shown by the immunoblot perfomed with an antibody to Drp1. Actin was used as a loading control.
(B and C) Analysis of Bax insertion in the outer mitochondrial membrane by alkali treatment and Bax oligomerization by the trypsin digestion assay. HeLa cells
were transfected as indicated in (A). Seventy-two hours after transfection, apoptosis was induced with 3 mM ActD (+ ActD). Four hours later, mitochondria were
isolated and analyzed for Bax insertion by alkali treatment (inserted Bax) or Bax oligomerization by trypsin digestion (Tr-Bax). Tr-Bax was also analyzed in
untreated HeLa cells ( ActD). Prohibitin was used as a mitochondrial loading control. Note that although Bax insertion was similar in cells transfected with
pCI, Drp1 WT, or Drp1 R247A/E vectors, Tr-Bax levels were significantly lower in cells expressing Drp1 R247A/E or Bcl-2 as shown in (C), which is a compilation
of results from four different experiments performed for pCI, Bcl-2, Drp1 R247A, and Drp1 R247E. Results represent a quantification of the immunoblots for
trypsin-resistant Bax. Mean values ± SEM are shown for six independent experiments with *p < 0.05, **p < 0.01.
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Figure 7. Expression of Drp1 R247A/E Delays Cell Death
(A and B) HeLa cells were transfected with an empty vector (pCI) or with plasmids encoding Bcl-2, Drp1WT, or Drp1 R247E. Seventy-two hours later, cell cultures
were treated with 3 mM Act D (A) or UV- irradiated (60 mJ/cm2) (B) and apoptosis quantified 6 hr later by Annexin V staining and FACS analysis. Values are the
average of six independent experiments ± SEM. **p < 0.01; ***p < 0.001; (n.s.), not significant.
(C) Model explaining the role of mitochondrial membrane hemifission or hemifusion intermediates in Bax oligomerization. During apoptosis, Bax is recruited to the
outer mitochondrial membrane by tBid (or other BH3 only proteins) where it inserts. At the same time, Drp1 constricts the organelle as indicated by red arrow-
heads, triggering the formation of a hemifission intermediate. This membrane remodeling (dark brown part of the membrane) promotes Bax oligomerization. We
speculate that contact sites between the inner and outer membranes, which are enriched in CL, could also be privileged sites for the formation of hemifusion
intermediates, independently of Drp1. Contact sites could therefore represent additional sites in which Bax oligomerization would occur.oligomers could increase membrane tension and stretching,
compromising the tightness of the membrane hemifusion/hemi-
fission path and therefore inducing leakage of contents. Thus,(D) HeLa cells were transfected as indicated in (A). Seventy-two hours later cells
detachment from the culture dish and immunostained for cytochrome c. Cells we
cytochrome c staining was counted. Histograms display the means of three inde
(E) Analysis of Bax oligomerization by size-exclusion chromatography. HeLa cells
were treated with 3 mMActD to induce apoptosis. Six hours later mitochondria we
were not exposed to ActD, as a control. Proteins were extracted from membrane
tography. Proteins in the eluted fractions were precipitated with tricholoroacetic a
nanogram recombinant Bax was loaded on every blot (labeled with an asterisk)
iluminescence detection of proteins, allowing direct comparison of all immunoblo
shows levels of Bax that were associated with mitochondria before extraction.
a loading control) were also blotted.
See also Figure S5.hemifusion/hemifission intermediates could be thought of as
an Achilles’ heel targeted by Bax to damage the outer mitochon-
drial membrane and trigger cytochrome c release.were treated with ActD for 4 hr in the presence of 100 mM z-VAD to avoid their
re analyzed by fluorescence microscopy and the number of cells with diffused
pendent experiments ± SEM; ***p < 0.001.
were transfected as indicated in (A). Seventy-two hours after transfection, cells
re isolated from cells undergoing apoptosis and from pCI transfected cells that
s with 2% CHAPS in 200 mM NaCl and fractionated by size-exclusion chroma-
cid and separated by SDS-PAGE before Bax immunoblotting (Right panel). One
to control that every blot was exposed similarly to X-ray film during the chem-
ts. In addition, Bcl-xL and Tom 20 were used as loading controls. The left panel
Results confirm those shown in (B, lower panel). Drp1 and mHsp70 (used as
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EXPERIMENTAL PROCEDURES
Liposome Preparation
In most experiments, liposomes were prepared as described by Lucken-
Ardjomande et al. (2008). For lipidmixing assays, lipidmixtures at the indicated
ratios were codissolved in chloroform/methanol (2:1). Organic solvents were
removed by evaporation under nitrogen stream followed by incubation under
vacuum for 2 hr. Dried lipid films were resuspended in the required buffers.
LUVs were formed using 10 freeze/thaw cycles and two polycarbonate mem-
branes of 0.2 mm pore size for extrusion (Nucleopore, San Diego, CA, USA).
Unless otherwise stated, liposome composition was PC/PE/CL (54:20:26,
mol/mol). Egg yolk PC, bovine heart CL, bovine brain PE, and bovine brain
LPC were from Sigma or Avanti.
Lipid Mixing and Aqueous Content Mixing Assays in Large
Unilamellar Vesicles
The resonance energy transfer assay of Struck et al. (1981) was used tomonitor
membrane lipidmixing.BrieflyPC/PE/CL (54:20:26) LUVscontaining2mol%of
NBD-PE and 2mol%Rh-PEweremixed with 9-fold excess of unlabeled LUVs.
NBD-PE emission wasmonitored at 530 nmwith the excitation wavelength set
at 465 nm (slits, 4 nm). A 515 nm cut-off filter was placed between the sample
and the emission monochromator to avoid scattering interference. Inner
monolayer lipidmixingwasmeasured using asymmetrically labeledmembrane
vesicles produced by the quenching of the outer leaflet NBD-PE fluorescence
upon addition of sodium dithionite. Dithionite was removed by gel filtration in
Sephadex G-25, using 125 mM KCl as elution buffer.
Content mixing wasmonitored by the ANTS/DPX assay performed by Ellens
et al. (1985). LUVs containing either (1) 25 mM ANTS, 40 mMNaCl, and 10 mM
HEPES, (2) 90mMDPX and 10mMHEPES, or (3) 12.5 mMANTS, 45mMDPX,
20 mM NaCl, and 10 mM HEPES were obtained by separating the nonencap-
sulated material by gel filtration on a Sephadex G-25 column eluted with
10 mM HEPES, 100 mM NaCl (pH 7.4). Osmolarity of all buffers was adjusted
to 200 mOsm. ANTS emission was monitored at 530 nm with the excitation
wavelength set at 360 nm (slits, 4 nm). A 470 nm cut-off filter was placed
between the sample and the emission monochromator to avoid scattering
interference. The 0% vesicle content mixing was set by using a 1:1 mixture
of ANTS and DPX liposomes. The 100% mixing of contents corresponded to
the fluorescence of the vesicles containing coencapsulated ANTS and DPX.
Unless otherwise stated, LUVs (60 mM lipid) were incubated with 1 mM ATP
and 1 mM MgCl2 prior to treatment with Drp1. Experiments were performed
in an SLM-8100 Aminco-Bowman luminescence spectrometer (Spectronic
Instruments, Rochester, NY, USA) in a thermostated 1 cm path length cuvette
with constant stirring at 37C.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
five figures and can be found with this article online at doi:10.1016/j.cell.
2010.08.017.
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